New drug combo shows promise in stomach infection battle
NCT ID NCT06977841
First seen Mar 22, 2026 · Last updated May 02, 2026 · Updated 7 times
Summary
This study tested different combinations of the acid-reducing drug tegoprazan with antibiotics to treat H. pylori, a common stomach infection that can lead to ulcers. 640 adults who had never been treated for H. pylori took one of several regimens for up to 14 days. The goal was to see which combination best cleared the infection with the fewest side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-DOSE DUAL THERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital (Xiamen), Fudan University
Xiamen, Fujian, 361015, China
Conditions
Explore the condition pages connected to this study.